Industry Execs Lobby US Secretaries Ross, Price On Medtech Issues

A group of top medical device executives led by AdvaMed CEO Scott Whitaker met the US commerce and health secretaries to discuss key industry issues, including device tax repeal, FDA user-fee reauthorization, trade policies and reimbursement.

AdvaMed CEO Scott Whitaker and a group of device executives met with US Department of Commerce Secretary Wilbur Ross and Health and Human Services Secretary Tom Price May 31. On top of the industry's agenda for the meetings was permanent repeal of the medical device tax and reauthorization of FDA device user fees (MDUFA IV). Reimbursement and trade issues were also discussed.

The primary objective of the May 31 meetings was to open channels of communication directly with the cabinet secretaries, AdvaMed...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation

UK Trails NHS 10-Year Plan With Launch Imminent

 
• By 

Healthcare product industries await publication of the NHS 10-Year Plan, due out the coming days, which will focus on health generally not just the NHS, UK health secretary Wes Streeting said during a final prelaunch event on 24 June.

New EU Rules Limit Chinese Participation In Medtech Procurement

 

From June 30, new European Commission rules will attempt to redress an imbalance in medtech trade between the EU and the People’s Republic of China.

Mexico’s New Procurement Rules Aim To Increase Healthcare Investment, But May Face Legal Trouble

 

Legal experts warn, however, that new Mexican procurement rules are discriminatory and could be challenged in the courts.